People with severe symptoms of chronic graft versus host disease (GvHD) often need to use multiple treatments to manage their condition. In recent years, a new class of medicines known as kinase ...

In this randomized controlled trial, axatilimab effectively managed symptoms in patients with recurrent or refractory graft ...

Allogeneic hematopoietic stem-cell transplantation is a curative therapy for a range of hematologic disorders. 1-3 Chronic graft-versus-host disease (GVHD) affects approximately half of transplant ...

For permission requests, please contact NEJM Reprints at [email protected] ...

Panelists give an overview of chronic graft-vs-host disease, its history of treatment, how it is handled in the modern day, and the study design of AGAVE-201. NEWS All News FDA Briefs Oncology Icons ...

New York, USA, Sept. 22, 2024 (GLOBE NEWSWIRE) -- Graft versus Host Disease Market to Increase at a CAGR of 9.9% During the Study Period (2020–2034) | DelveInsight DelveInsight’s Graft versus ...

More information: Daniel Wolff et al, Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease, New England Journal of Medicine (2024). DOI: 10.1056/NEJMoa2401537 Mohamad Mohty ...

Panelists give an overview of Graft-vs-host Disease and the modern landscape of treatment. NEWS All News FDA Briefs Oncology Icons Special Reports Voices from the Field ...

Panelists discuss how axatilimab, a novel therapy for chronic graft-versus-host disease (cGVHD), functions through a unique mechanism of action compared to other treatments, highlighting its potential ...

Panelists discuss how the current treatment landscape for chronic graft-versus-host disease includes a range of immunosuppressive approaches, from traditional corticosteroids and calcineurin ...

Results of the AGAVE-201 trial demonstrate a high incidence of response to axatilimab among patients with chronic graft-versus-host disease.

“However, the procedure can quickly turn into a severe and life-threatening condition for those who are affected by acute graft-versus-host disease in which the transplanted immune ... and for ...